Eisai
4523.T
#2353
Rank
NZ$13.63 B
Marketcap
NZ$48.37
Share price
-0.26%
Change (1 day)
0.76%
Change (1 year)
Eisai is a Japanese pharmaceutical company that is engaged in the R&D of drugs for the treatment of dementia and Alzheimer.

EPS for Eisai (4523.T)

EPS in 2025 (TTM): NZ$1.42

According to Eisai's latest financial reports the company's current EPS (TTM) is NZ$1.47. an increase over its 2024 EPS that were of NZ$1.65.

EPS history for Eisai from 2000 to 2025

Annual EPS

Year EPS Change
2025NZ$1.8511.85%
2024NZ$1.65-32.63%
2023NZ$2.455.52%
2022NZ$2.32-74.01%
2021NZ$8.94-66.58%
2020NZ$26.7598.24%
2019NZ$13.4917.01%
2018NZ$11.5337.78%
2017NZ$8.37-27.62%
2016NZ$11.5635.33%
2015NZ$8.55-2.82%
2014NZ$8.79-27.66%
2013NZ$12.16-27.49%
2012NZ$16.77-12.67%
2011NZ$19.2088.08%
2010NZ$10.21-11.06%
2009NZ$11.48-390.15%
2008NZ-$3.96-127.78%
2007NZ$14.2411.78%
2006NZ$12.744.38%
2005NZ$12.217.4%
2004NZ$11.3743.03%
2003NZ$7.9525.09%
2002NZ$6.3552.67%
2001NZ$4.1669.76%
2000NZ$2.45